Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT00433927 |
| Title | 5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC) |
| Recruitment | Unknown status |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | PD Dr. med. Volker Heinemann,Merck KGaA, Darmstadt, Germany |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | DEU |